| Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. |
| Xu XX, Yang W, Jackowski S, Rock CO. |
| J Biol Chem. 1995 Jun 9;270(23):14184-91. |
| PMID 7775479 |
| |
| Sequence, genomic structure, and chromosomal assignment of human DOC-2. |
| Albertsen HM, Smith SA, Melis R, Williams B, Holik P, Stevens J, White R. |
| Genomics. 1996 Apr 15;33(2):207-13. |
| PMID 8660969 |
| |
| DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. |
| Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. |
| Oncogene. 1998 May 7;16(18):2381-7. |
| PMID 9620555 |
| |
| Disabled-2 inactivation is an early step in ovarian tumorigenicity. |
| Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. |
| Oncogene. 1999 May 20;18(20):3104-13. |
| PMID 10340382 |
| |
| The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer. |
| Tseng CP, Ely BD, Pong RC, Wang Z, Zhou J, Hsieh JT. |
| J Biol Chem. 1999 Nov 5;274(45):31981-6. |
| PMID 10542228 |
| |
| Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2). |
| Sheng Z, He J, Tuppen JA, Sun W, Fazili Z, Smith ER, Dong FB, Xu XX. |
| Genomics. 2000 Dec 15;70(3):381-6. |
| PMID 11161789 |
| |
| Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation. |
| He J, Smith ER, Xu XX. |
| J Biol Chem. 2001 Jul 20;276(29):26814-8. Epub 2001 May 18. |
| PMID 11359772 |
| |
| The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. |
| Hocevar BA, Smine A, Xu XX, Howe PH. |
| EMBO J. 2001 Jun 1;20(11):2789-801. |
| PMID 11387212 |
| |
| Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. |
| Morris SM, Cooper JA. |
| Traffic. 2001 Feb;2(2):111-23. |
| PMID 11247302 |
| |
| Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. |
| Smith ER, Capo-chichi CD, He J, Smedberg JL, Yang DH, Prowse AH, Godwin AK, Hamilton TC, Xu XX. |
| J Biol Chem. 2001 Dec 14;276(50):47303-10. Epub 2001 Sep 27. |
| PMID 11577091 |
| |
| DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. |
| Wang SC, Makino K, Xia W, Kim JS, Im SA, Peng H, Mok SC, Singletary SE, Hung MC. |
| Oncogene. 2001 Oct 18;20(47):6960-4. |
| PMID 11687976 |
| |
| The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2. |
| Zhou J, Hsieh JT. |
| J Biol Chem. 2001 Jul 27;276(30):27793-8. Epub 2001 May 22. |
| PMID 11371563 |
| |
| Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. |
| Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, Traub LM. |
| EMBO J. 2002 Sep 16;21(18):4915-26. |
| PMID 12234931 |
| |
| Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. |
| Rosenbauer F, Kallies A, Scheller M, Knobeloch KP, Rock CO, Schwieger M, Stocking C, Horak I. |
| EMBO J. 2002 Feb 1;21(3):211-20. |
| PMID 11823414 |
| |
| Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis. |
| Yang DH, Smith ER, Roland IH, Sheng Z, He J, Martin WD, Hamilton TC, Lambeth JD, Xu XX. |
| Dev Biol. 2002 Nov 1;251(1):27-44. |
| PMID 12413896 |
| |
| Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. |
| He J, Xu J, Xu XX, Hall RA. |
| Oncogene. 2003 Jul 17;22(29):4524-30. |
| PMID 12881709 |
| |
| Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer. |
| Zhou J, Scholes J, Hsieh JT. |
| J Biol Chem. 2003 Feb 28;278(9):6936-41. Epub 2002 Dec 8. |
| PMID 12473651 |
| |
| Disabled-2 is a negative regulator of integrin alpha(IIb)beta(3)-mediated fibrinogen adhesion and cell signaling. |
| Huang CL, Cheng JC, Liao CH, Stern A, Hsieh JT, Wang CH, Hsu HL, Tseng CP. |
| J Biol Chem. 2004 Oct 1;279(40):42279-89. Epub 2004 Jul 26. |
| PMID 15280374 |
| |
| Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. |
| Hidalgo A, Baudis M, Petersen I, Arreola H, Pina P, Vazquez-Ortiz G, Hernandez D, Gonzalez J, Lazos M, Lopez R, Perez C, Garcia J, Vazquez K, Alatorre B, Salcedo M. |
| BMC Cancer. 2005 Jul 9;5:77. |
| PMID 16004614 |
| |
| Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). |
| Prunier C, Howe PH. |
| J Biol Chem. 2005 Apr 29;280(17):17540-8. Epub 2005 Feb 25. |
| PMID 15734730 |
| |
| The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. |
| Zhoul J, Hernandez G, Tu SW, Huang CL, Tseng CP, Hsieh JT. |
| Cancer Res. 2005 Nov 1;65(21):9906-13. |
| PMID 16267015 |
| |
| Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization. |
| Nakagawa Y, Yoshida A, Numoto K, Kunisada T, Wai D, Ohata N, Takeda K, Kawai A, Ozaki T. |
| Oncol Rep. 2006 Feb;15(2):297-303. |
| PMID 16391845 |
| |
| Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle. |
| Zhou J, Fan J, Hsieh JT. |
| Cancer Res. 2006 Sep 15;66(18):8954-8. |
| PMID 16982733 |
| |
| Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. |
| Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. |
| Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6. |
| PMID 17671122 |
| |
| Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to Disabled-2 and PtdIns(4,5)P2. |
| Spudich G, Chibalina MV, Au JS, Arden SD, Buss F, Kendrick-Jones J. |
| Nat Cell Biol. 2007 Feb;9(2):176-83. Epub 2006 Dec 24. |
| PMID 17187061 |
| |
| Disabled-2 is an epithelial surface positioning gene. |
| Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX. |
| J Biol Chem. 2007 Apr 27;282(17):13114-22. Epub 2007 Mar 5. |
| PMID 17339320 |
| |
| The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. |
| Jiang Y, Prunier C, Howe PH. |
| Oncogene. 2008 Mar 20;27(13):1865-75. Epub 2007 Oct 8. |
| PMID 17922036 |
| |
| Morphogenesis of human endothelial cells is inhibited by DAB2 via Src. |
| Orlandini M, Nucciotti S, Galvagni F, Bardelli M, Rocchigiani M, Petraglia F, Oliviero S. |
| FEBS Lett. 2008 Jul 23;582(17):2542-8. Epub 2008 Jun 26. |
| PMID 18582465 |
| |
| C-Fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm development. |
| Yang DH, Smith ER, Cai KQ, Xu XX. |
| Dev Dyn. 2009 Mar;238(3):514-23. |
| PMID 19191218 |
| |